The squamous cell carcinoma of the head and neck treatment market, which was USD 12 billion in 2022, is expected to rise to USD 24.80 billion by 2030, and is projected to grow at a compound annual growth rate (CAGR) of 9.50% during the forecast period from 2023 to 2030. This strong growth reflects increasing incidence rates of head and neck cancers globally, particularly HPV-associate... https://www.databridgemarketresearch.com/reports/global-squamous-cell-carcinoma-of-the-head-and-neck-treatment-market